Announced Mon, 13 Apr · 18:00 IST

Disclousre Under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹1821.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4+1.6+14.8+12.9+15.8+16.4+30.1+30.0+28.1+54.2
Up moveDown movePending
AI summary

Fredun Pharmaceuticals Ltd has filed a disclosure under SEBI's Insider Trading Regulations. The specific document content was not accessible (BSE returned an error page), but Regulation 7(2) requires promoters, directors, and key managerial personnel to disclose their shareholding or transaction details in the company. Such filings typically involve significant share purchases, sales, or changes in beneficial ownership by insiders. The filing indicates that company insiders have made disclosures regarding their dealings in the company's shares, which is a mandatory compliance requirement.

Likely market impact

Regulation 7(2) disclosures by insiders can signal insider confidence or selling pressure. Investors should monitor subsequent filings or corporate announcements for details on the nature and scale of the insider transaction.